Sweet DG, Carnielli VP, Greisen G, Hallman M, Klebermass-Schrehof K, Ozek E, et al. European Consensus Guidelines on the Management of Respiratory Distress Syndrome: 2022 Update. Neonatology. 2023;120:3–23. https://doi.org/10.1159/000528914.

Article  PubMed  Google Scholar 

Aldana-Aguirre JC, Pinto M, Featherstone RM, Kumar M. Less invasive surfactant administration versus intubation for surfactant delivery in preterm infants with respiratory distress syndrome: a systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed. 2017;102:F17–F23. https://doi.org/10.1136/archdischild-2015-310299.

Article  PubMed  Google Scholar 

Kakkilaya V, Gautham KS. Should less invasive surfactant administration (LISA) become routine practice in US neonatal units? Pediatr Res. 2023;93:1188–98. https://doi.org/10.1038/s41390-022-02265-8.

Article  PubMed  Google Scholar 

Taylor G, Jackson W, Hornik CP, Koss A, Mantena S, Homsley K, et al. Surfactant administration in preterm infants: drug development opportunities. J Pediatr. 2019;208:163–8.

Article  CAS  PubMed  Google Scholar 

Survanta [package insert] North Chicago, IL: AbbVie, Inc; 2023. https://www.rxabbvie.com/pdf/survanta_pi.pdf Accessed December 17, 2023.

Curosurf [package insert] Parma, Italy: Chiesi Farmaceutici SpA; 2023. https://resources.chiesiusa.com/Curosurf/CUROSURF_PI.pdf). Accessed December 17, 2023.

Polin RA, Carlo WA, Committee on Fetus and Newborn; American Academy of Pediatrics. Surfactant replacement therapy for preterm and term neonates with respiratory distress. Pediatrics. 2014;133:156–63. https://doi.org/10.1542/peds.2013-3443.

Article  PubMed  Google Scholar 

Singh N, Halliday HL, Stevens TP, Suresh G, Soll R, Rojas-Reyes MX. Comparison of animal-derived surfactants for the prevention and treatment of respiratory distress syndrome in preterm infants. Cochrane Database Syst Rev. 2015;2015:CD010249. https://doi.org/10.1002/14651858.CD010249.pub2.

Article  PubMed  PubMed Central  Google Scholar 

Tridente A, De Martino L, De Luca D. Porcine vs bovine surfactant therapy for preterm neonates with RDS: systematic review with biological plausibility and pragmatic meta-analysis of respiratory outcomes. Respir Res. 2019;20:28 https://doi.org/10.1186/s12931-019-0979-0.

Article  PubMed  PubMed Central  Google Scholar 

Sánchez Luna M, Bacher P, Unnebrink K, Martinez-Tristani M, Ramos Navarro C. Beractant and poractant alfa in premature neonates with respiratory distress syndrome: a systematic review of real-world evidence studies and randomized controlled trials. J Perinatol. 2020;40:1121–34. https://doi.org/10.1038/s41372-020-0603-7.

Article  PubMed  PubMed Central  Google Scholar 

Dargaville PA, Kamlin COF, Orsini F, Wang X, De Paoli AG, Kanmaz Kutman HG, et al. Effect of minimally invasive surfactant therapy vs sham treatment on death or bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome: The OPTIMIST-a randomized clinical trial. JAMA. 2021;326:2478–87. https://doi.org/10.1001/jama.2021.21892.

Article  CAS  PubMed  Google Scholar 

Kribs A, Roll C, Göpel W, Wieg C, Groneck P, Laux R, et al. Nonintubated surfactant application vs conventional therapy in extremely preterm infants: a randomized clinical trial. JAMA Pediatr. 2015;169:723–30. https://doi.org/10.1001/jamapediatrics.2015.0504.

Article  PubMed  Google Scholar 

Silverman WA, Andersen DH. A controlled clinical trial of effects of water mist on obstructive respiratory signs, death rate and necropsy findings among premature infants. Pediatrics. 1956;17:1–10.

CAS  PubMed  Google Scholar 

Gupta BK, Saha AK, Mukherjee S, Saha B. Minimally invasive surfactant therapy versus InSurE in preterm neonates of 28 to 34 weeks with respiratory distress syndrome on non-invasive positive pressure ventilation-a randomized controlled trial. Eur J Pediatr. 2020;179:1287–93. https://doi.org/10.1007/s00431-020-03682-9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr. 1978;92:529–34. https://doi.org/10.1016/s0022-3476(78)80282-0.

Article  CAS  PubMed  Google Scholar 

Chiang MF, Quinn GE, Fielder AR, Ostmo SR, Paul Chan RV, Berrocal A, et al. International Classification of Retinopathy of Prematurity, Third Edition. Ophthalmology. 2021;128:e51–e68. https://doi.org/10.1016/j.ophtha.2021.05.031.

Article  PubMed  Google Scholar 

Kliegman RM, Walsh MC. Neonatal necrotizing enterocolitis: pathogenesis, classification, and spectrum of illness. Curr Probl Pediatr. 1987;17:213–88. https://doi.org/10.1016/0045-9380(87)90031-4.

Article  CAS  PubMed  Google Scholar 

Sehgal A, McNamara PJ. Does echocardiography facilitate determination of hemodynamic significance attributable to the ductus arteriosus? Eur J Pediatr. 2009;168:907–14. https://doi.org/10.1007/s00431-009-0983-3.

Article  PubMed  Google Scholar 

Jensen EA, Dysart K, Gantz MG, McDonald S, Bamat NA, Keszler M, et al. The diagnosis of bronchopulmonary dysplasia in very preterm infants. an evidence-based approach. Am J Respir Crit Care Med. 2019;200:751–9. https://doi.org/10.1164/rccm.201812-2348OC.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Akar S, Topcuoglu S, Dincer E, Ozalkaya E, Karatekin G, Gokmen Yildirim T. Comparison of efficacy of beractant and poractant treatment performed with minimal invasive technique. Iran J Neonatol. 2021. https://doi.org/10.22038/ijn.2020.48388.1838.

Göpel W, Kribs A, Ziegler A, Laux R, Hoehn T, Wieg C, et al. Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomised, controlled trial. Lancet. 2011;378:1627–34. https://doi.org/10.1016/S0140-6736(11)60986-0.

Article  CAS  PubMed  Google Scholar 

Trembath A, Hornik CP, Clark R, Smith PB, Daniels J, Laughon M, et al. Comparative effectiveness of surfactant preparations in premature infants. J Pediatr. 2013;163:955–60.e1. https://doi.org/10.1016/j.jpeds.2013.04.053.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Paul S, Rao S, Kohan R, McMichael J, French N, Zhang G, et al. Poractant alfa versus beractant for respiratory distress syndrome in preterm infants: a retrospective cohort study. J Paediatr Child Health. 2013;49:839–44. https://doi.org/10.1111/jpc.12300.

Article  PubMed  Google Scholar 

Fujii AM, Patel SM, Allen R, Doros G, Guo CY, Testa S. Poractant alfa and beractant treatment of very premature infants with respiratory distress syndrome. J Perinatol. 2010;30:665–70. https://doi.org/10.1038/jp.2010.20.

Article  CAS  PubMed  Google Scholar 

Dizdar EA, Sari FN, Aydemir C, Oguz SS, Erdeve O, Uras N, et al. A randomized, controlled trial of poractant alfa versus beractant in the treatment of preterm infants with respiratory distress syndrome. Am J Perinatol. 2012;29:95–100. https://doi.org/10.1055/s-0031-1295648.

Article  PubMed  Google Scholar 

Ramanathan R, Rasmussen MR, Gerstmann DR, Finer N, Sekar K, North American Study Group. A randomized, multicenter masked comparison trial of poractant alfa (Curosurf) versus beractant (Survanta) in the treatment of respiratory distress syndrome in preterm infants. Am J Perinatol. 2004;21:109–19. https://doi.org/10.1055/s-2004-823779.

Article  PubMed  Google Scholar 

Lu KW, Pérez-Gil J, Taeusch H. Kinematic viscosity of therapeutic pulmonary surfactants with added polymers. Biochim Biophys Acta. 2009;1788:632–7. https://doi.org/10.1016/j.bbamem.2009.01.005.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vento M, Bohlin K, Herting E, Roehr CC, Dargaville PA. Surfactant administration via thin catheter: a practical guide. Neonatology. 2019;116:211–26. https://doi.org/10.1159/000502610.

Article  CAS  PubMed  Google Scholar 

Terek D, Gonulal D, Koroglu OA, Yalaz M, Akisu M, Kultursay N. Effects of two different exogenous surfactant preparations on serial peripheral perfusion index and tissue carbon monoxide measurements in preterm infants with severe respiratory distress syndrome. Pediatr Neonatol. 2015;56:248–55. https://doi.org/10.1016/j.pedneo.2014.11.004.

Article  PubMed  Google Scholar 

Brown S, Hurren J, Sartori H. Poractant alfa versus beractant for neonatal respiratory distress syndrome: a retrospective cost analysis. J Pediatr Pharmacol Ther. 2018;23:367–71. https://doi.org/10.5863/1551-6776-23.5.367.

Article  PubMed  PubMed Central  Google Scholar 

Sekar K, Fuentes D, Krukas-Hampel MR, Ernst FR. Health economics and outcomes of surfactant treatments for respiratory distress syndrome among preterm infants in US Level III/IV neonatal intensive care units. J Pediatr Pharmacol Ther. 2019;24:117–27. https://doi.org/10.5863/1551-6776-24.2.117.

Article  PubMed  PubMed Central  Google Scholar